82466-4
riTUXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay
Active
Part Descriptions
LP220253-1 riTUXimab
Rituximab (trade names Rituxan, MabThera and Zytux) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is thus used to treat diseases that are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemia, transplant rejection and autoimmune disorders. Rituximab is also used with methotrexate to treat moderate-to-severe forms of rheumatoid arthritis to decrease joint pain and swelling. It is usually used for arthritis only after other medications have not worked. It is also used to treat certain types of blood vessel disease (such as Wegener's granulomatosis, microscopic polyangiitis).
Source: Regenstrief LOINC
LP220254-9 riTUXimab Ab
Rituximab antibodies are measured to detect and assess the development of antibodies against the therapeutic protein rituximab (tradenames Mabthera and Rituxan). The formation of anti-drug antibodies (ADA) against biopharmaceutical products can lead to loss of efficacy or potentially serious side effects.
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- riTUXimab Ab:
MCnc: Pt: Ser/Plas: Qn: IA - Long Common Name
- riTUXimab Ab [Mass/volume] in Serum or Plasma by Immunoassay
- Short Name
- riTUXimab Ab SerPl IA-mCnc
- Display Name
- riTUXimab Ab IA [Mass/Vol]
- Consumer Name Alpha Get Info
- riTUXimab antibody, Blood
Part Model Get Info
- Component
- riTUXimab Ab
LP220254-9
- Analyte
- riTUXimab Ab
LP220254-9
- Component Numerator
- riTUXimab Ab
LP220254-9
- Component Numerator Core
- riTUXimab
LP220253-1
- Component Numerator Core Suffix
- Ab
LP20667-9
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- MCnc
LP6827-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- Qn
LP7753-9
- Method
- IA
LP217197-5
Basic Attributes
- Class
- SERO
- Type
- Laboratory
- First Released
- Version 2.58
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 12472
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Rituximab Ab: |
| el-GR | Greek (Greece) | Ριτουξιμάμπη Αντίσωμα: Synonyms: IA MCnc Pt Qn SERO Αντίσωμα Ορός Ορός/Πλάσμα Πλάσμα Ριτουξιμάμπη |
| es-ES | Spanish (Spain) | Rituximab Anticuerpos: Synonyms: Cuantitativo |
| es-MX | Spanish (Mexico) | riTUXimab Ab: |
| fr-FR | French (France) | Rituximab Ac: |
| it-IT | Italian (Italy) | Rituximab Ab: Synonyms: anticorpo Concentrazione di Massa Immunoassay Plasma Punto nel tempo (episodio) Siero Siero o Plasma Sierologia (anticorpi e la maggior parte degli ant |
| nl-NL | Dutch (Netherlands) | rituximab As: Synonyms: antistof; |
| zh-CN | Chinese (China) | 利妥昔单抗 抗体: Synonyms: Ab; |
Example Units
| Unit | Source |
|---|---|
| ng/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://